Carrie Brownstein
Direktor/Vorstandsmitglied bei SHATTUCK LABS, INC.
Vermögen: 1 Mio $ am 31.05.2024
Aktive Positionen von Carrie Brownstein
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHATTUCK LABS, INC. | Direktor/Vorstandsmitglied | 22.10.2021 | - |
| Independent Dir/Board Member | 22.10.2021 | - |
Karriereverlauf von Carrie Brownstein
Ehemalige bekannte Positionen von Carrie Brownstein
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.10.2022 | 19.01.2024 |
| CELLECTIS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 13.04.2020 | 28.09.2022 |
| CELGENE | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2017 | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 01.08.2012 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
Ausbildung von Carrie Brownstein
| Tufts University School of Medicine | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
- Börse
- Insiders
- Carrie Brownstein
- Erfahrung
